Exhibit (b) to Form 10-QSB
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 and 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): June 29, 2001
Human Pheromone Sciences, Inc.
------------------------------
(Exact name of Registrant as specified in its charter)
CALIFORNIA 0-23544 94 -3107202
---------- ------- -----------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
84 West Santa Clara Street, Suite 720, San Jose, California 95113
- ----------------------------------------------------------- -----
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (408) 938-3030
--------------
-----------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
Exhibit (b) to Form 10-QSB
INFORMATION TO BE INCLUDED IN THE REPORT
ITEM 4. CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANTS
(a) As reported on Form 8-K dated June 15, 2001, the Audit
Committee of the Board of Directors of the Company authorized
the termination of BDO Seidman LLP as auditors of the Company
effective that day.
(b) As of June 29, 2001, the Company engaged Singer, Lewak,
Greenbaum & Goldstein, LLP as the Company's independent
auditors to replace BDO Seidman, LLP.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HUMAN PHEROMONE SCIENCES, INC.
By: /s/ William P. Horgan
------------------------------------------
William P. Horgan, Chief Executive Officer